An observational study of intravenous medication errors in the United Kingdom and in Germany.

Department of Practice and Policy, School of Pharmacy, University of London, UK.
International Journal of Clinical Pharmacy (Impact Factor: 1.27). 07/2003; 25(3):104-11. DOI: 10.1023/A:1024009000113
Source: PubMed

ABSTRACT To investigate the incidence and the severity of intravenous (i.v.) drug preparation and administration errors in two countries and three pharmacy services.
A disguised observational method was used to record details of the preparation and administration of prescribed i.v. drugs on two wards in each of three teaching hospitals: one with a traditional British ward pharmacy service (TBP) and two hospitals in Germany, one with a traditional ward stock supply (TGP) and one with a satellite pharmacy service (GSP) with unit dose system. Main outcome measures: Errors in i.v. drug preparation and administration and their potential significance.
The number of observed preparations/administrations were: TBP 77/63, TGP 126/109 and GSP 134/106. The preparation error rates were: TBP 22% (95% confidence interval: 13-31%), TGP 23% (16-30%) and GSP 31% (23-39%). The administration error rates were TBP 27% (16-38%), TGP 49% (39-58%) and GSP 22% (14-30%). The percentage of administration errors on the wards with TGP was statistically significantly higher than in the other two services. Common errors at the study sites with TBP and GSP were omissions. Wrong rate of administration occurred most frequently on the wards with TGP. The majority of errors were likely to be of 'moderate' to 'severe' outcome. Careful drug chart reading could possibly reduce omission errors on the wards with TBP. A change of the German nursing law ('Krankenpflegegesetz') to legally entitle nurses to administer i.v. drugs could probably result in better training, national guidelines and standards.
This study found a high rate of i.v. medication errors of moderate to severe significance. Changes in practice should be considered to make i.v. therapy safer for patients.


Available from: Nick Barber, Apr 19, 2015
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background:Infusion therapy through intravenous (IV) access is a therapeutic option used in the treatment of many hospitalized patients. IV therapy is complex, potentially dangerous and error prone. The objectives were to ascertain the drug-related problems (DRPs) involved in IV medication administration and further to develop strategies to reduce and prevent the occurrence of DRPs during IV administration.Materials and Methods:A prospective observational study was carried out for a period of 4 months. Patients receiving more than two medications through IV route were included and studied.Results:Of 110 patients, 76 (69.09%) were male and the rest were female. Nearly, half of the patients (46.3%, n = 51) were reported with DRPs. Of the 80 DRPs (72.72%) documented, 61 problems (55.4%) were seen in patients given IV medications through peripheral line. Among the DRPs majority seen were incompatibilities (40.9%, n = 45), followed by complications developed (12.7%, n = 14), errors in rate of administration (10.9%), and dilution errors (8%). To study the association of DRPs among gender, statistical analysis was performed and significant association was seen between DRPs and gender (P = 0.03).Conclusion:Among the reported DRPs, simultaneous IV administration of two incompatible drugs was the main predicament faced.
    03/2014; 5(2):49-53. DOI:10.4103/0976-0105.134984
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: Serious and life-threatening adverse drug events are often attributed to intravenous medication administration errors. Although smart infusion pumps are increasingly being adopted by hospitals to prevent such errors, data are lacking on their effectiveness in clinical practice. Aim: To measure and characterise intravenous medication administration errors and their clinical significance before and after the implementation of smart infusion pumps. Method: In the pre-intervention period, an independent observer over 41 working days recorded the prescribing and administration details of infusions administered via the IMED Gemini Volumetric Infusion Pumps. 20 months after the introduction of the smart pumps – Alaris GP Volumetric Pump with Guardrails software – a repeat audit was conducted over 27 working days. Only infusions containing drugs that were to be incorporated into Guardrails (the medication–error– prevention software of the Alaris GP pump) were evaluated. The clinical significance of the identified errors was evaluated by 2 independent assessors (pharmacist and doctor) and rated as 'low', 'moderate', 'high' or 'extreme'. Results: In the pre-intervention period, 76 infusions (n = 432, 18%) had one or more errors compared to 25 infusions (n = 266, 9.4%) following the introduction of the smart pumps. Of the 165 infusions administered using Guardrails, only 6 infusions with errors (3.6%) were identified. When drugs were infused with the Alaris GP pumps without Guardrails, the number of errors post-intervention when compared with errors in the pre-intervention period were not statistically significant (p = 0.8). When Alaris GP pumps with Guardrails were used there were no errors of 'extreme' clinical significance and only 1 error of 'high' clinical significance compared to the pre-intervention period where 1 'extreme' and 30 errors with 'high' clinical significance were identified. Conclusion: Alaris GP pumps with Guardrails resulted in significant reductions in the number and clinical significance of intravenous medication administration errors. J Pharm Pract Res 2011; 41: 192-5.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: Preventing intravenous (IV) preparation errors will improve patient safety and reduce costs by an unknown amount. Objective: To estimate the financial benefit of robotic preparation of sterile medication doses compared to traditional manual preparation techniques. Methods: A probability pathway model based on published rates of errors in the preparation of sterile doses of medications was developed. Literature reports of adverse events were used to project the array of medical outcomes that might result from these errors. These parameters were used as inputs to a customized simulation model that generated a distribution of possible outcomes, their probability, and associated costs. Results: By varying the important parameters across ranges found in published studies, the simulation model produced a range of outcomes for all likely possibilities. Thus it provided a reliable projection of the errors avoided and the cost savings of an automated sterile preparation technology. The average of 1,000 simulations resulted in the prevention of 5,420 medication errors and associated savings of $288,350 per year. The simulation results can be narrowed to specifi c scenarios by fixing model parameters that are known and allowing the unknown parameters to range across values found in previously published studies. Conclusions: The use of a robotic device can reduce health care costs by preventing errors that can cause adverse drug events.
    Hospital pharmacy 09/2014; 49:731-39. DOI:10.1310/hpj4808-731

Similar Publications